Dow Jones
37 775,38 +22,07 (+0,06 %) Nasdaq
15 601,50 -81,87 (-0,52 %) Nikkei 225
36 818,81 -1 260,89 (-3,31 %) EUR/USD
1,0620 -0,0026 (-0,24 %) HANG SENG
16 143,01 -242,86 (-1,48 %) Bitcoin EUR
57 044,41 -995,77 (-1,72 %)
McKesson Corporation (MCK)
Échanges après Bourse :
McKesson Corporation
6555 State Highway 161
Irving, TX 75039
United States
972 446 4800
https://www.mckesson.com
Secteur(s): Healthcare
Secteur d’activité: Medical Distribution
Employés à temps plein: 45 000
Dirigeants clés
| Nom | Titre | Payer | Exercé | Année de naissance |
|---|---|---|---|---|
| Mr. Brian S. Tyler Ph.D. | CEO & Director | 7,22M | 6,33M | 1967 |
| Mr. Britt J. Vitalone | Executive VP & CFO | 3,04M | 1,1M | 1969 |
| Ms. LeAnn B. Smith | Executive VP & Chief Human Resources Officer | 1,32M | S.O. | 1975 |
| Ms. Lori A. Schechter J.D. | Board & Enterprise Risk Advisor | 2,6M | 1,02M | 1962 |
| Mr. Napoleon B. Rutledge Jr. | Senior VP, Controller & Chief Accounting Officer | S.O. | S.O. | 1972 |
| Mr. Francisco Fraga | Executive VP, Chief Information Officer & Chief Technology Officer | S.O. | S.O. | 1973 |
| Rachel Rodriguez | Vice President of Investor Relations | S.O. | S.O. | S.O. |
| Ms. Michele Lau | Executive VP & Chief Legal Officer | S.O. | S.O. | 1977 |
| Mr. Pete Slone | Senior Vice President of Corporate Public Affairs | S.O. | S.O. | S.O. |
| Mr. Kirk Kaminsky | President of The US Pharmaceutical & Specialty Solutions Business | S.O. | S.O. | S.O. |
Description
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment offers distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Gouvernance d’entreprise
L’ISS Governance QualityScore de McKesson Corporation en date du 1 avril 2024 est 3. Les scores principaux sont Audit : 9; Société : 1; Droits des actionnaires : 4; Compensation : 4.
